HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristian Hveem Selected Research

Sp1 Transcription Factor

1/2016MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.
9/2014Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649).
9/2012SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer.
1/2012MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.
2/2011The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristian Hveem Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 05/2009
12Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2007
10Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 02/2014
8Lung Neoplasms (Lung Cancer)
01/2020 - 04/2008
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 11/2013
6Myocardial Infarction
01/2022 - 04/2014
6Obesity
01/2022 - 07/2003
5Heart Failure
01/2022 - 12/2016
5Inflammation (Inflammations)
01/2021 - 06/2012
4Coronary Disease (Coronary Heart Disease)
12/2021 - 06/2012
4Sleep Initiation and Maintenance Disorders (Insomnia)
10/2021 - 06/2012
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 10/2012
4Heartburn (Pyrosis)
01/2017 - 03/2013
4Prostatic Neoplasms (Prostate Cancer)
09/2012 - 05/2010
3Insulin Resistance
01/2022 - 01/2012
3Stroke (Strokes)
01/2022 - 01/2019
3Hypertension (High Blood Pressure)
01/2022 - 12/2015
3Venous Thromboembolism
01/2020 - 11/2018
3Adenocarcinoma
01/2019 - 08/2008
3Hemochromatosis (Bronze Diabetes)
11/2017 - 09/2007
2Thyroid Neoplasms (Thyroid Cancer)
12/2021 - 01/2020
2Heart Diseases (Heart Disease)
12/2021 - 10/2021
2Gallstones (Gallstone)
01/2021 - 01/2017
2Atrial Fibrillation
01/2021 - 01/2018
2Gallbladder Neoplasms (Gallbladder Cancer)
01/2021 - 01/2020
2Genetic Risk Score
10/2020 - 01/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2018
2Gastroesophageal Reflux (GERD)
02/2016 - 07/2003
2Breast Neoplasms (Breast Cancer)
01/2016 - 05/2009
1Oropharyngeal Neoplasms
11/2022
1Nephrolithiasis
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Acne Vulgaris
01/2022
1Renal Insufficiency (Renal Failure)
01/2022
1Kidney Neoplasms (Kidney Cancer)
01/2022
1Isolated Systolic Hypertension
01/2022
1Iron Deficiencies
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Migraine Disorders (Migraine)
01/2022
1Abdominal Obesity
01/2022
1Cholangiocarcinoma
10/2021
1Kidney Diseases (Kidney Disease)
06/2021
1Melanoma (Melanoma, Malignant)
06/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Bipolar Disorder (Manic Depressive Psychosis)
01/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2011
9Biological ProductsIBA
01/2022 - 08/2011
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
9LipidsIBA
12/2021 - 11/2013
7Triglycerides (Triacylglycerol)IBA
01/2021 - 11/2013
6Pharmaceutical PreparationsIBA
01/2022 - 01/2019
6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2011
6Genetic Markers (Genetic Marker)IBA
01/2019 - 05/2009
5C-Reactive ProteinIBA
01/2021 - 06/2012
5AcidsIBA
01/2017 - 03/2013
5Sp1 Transcription FactorIBA
01/2016 - 02/2011
4IronIBA
01/2022 - 09/2007
4Troponin IIBA
01/2022 - 09/2016
3Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 11/2018
3LDL CholesterolIBA
12/2021 - 11/2013
3Dipeptidyl-Peptidase IV InhibitorsIBA
10/2021 - 01/2019
3CholesterolIBA
01/2021 - 11/2013
3oxidized low density lipoproteinIBA
12/2020 - 02/2014
3HDL CholesterolIBA
12/2015 - 11/2013
2Hormones (Hormone)IBA
01/2022 - 01/2012
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022 - 01/2019
2Sodium-Glucose Transport ProteinsIBA
01/2022 - 01/2019
2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2021 - 01/2020
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
10/2021 - 01/2019
2ProteomeIBA
01/2021 - 12/2020
2Gonadal Steroid Hormones (Sex Hormones)IBA
12/2020 - 07/2003
2Tryptophan (L-Tryptophan)FDA Link
01/2020 - 01/2017
2SmokeIBA
05/2018 - 02/2016
2AngiopoietinsIBA
01/2018 - 01/2016
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2018 - 01/2016
2Lipoproteins (Lipoprotein)IBA
12/2017 - 11/2013
2DNA (Deoxyribonucleic Acid)IBA
11/2017 - 01/2016
2P-2 (P 2)IBA
01/2016 - 05/2010
2CarcinogensIBA
04/2010 - 04/2008
1Oncogene Proteins (Oncogene Protein)IBA
11/2022
1Thyroid HormonesIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Lipoprotein(a)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1omega-Chloroacetophenone (Mace)IBA
01/2022
15-HT1F Serotonin ReceptorIBA
01/2022
1Troponin T (Troponin T1)IBA
01/2022
1lipoprotein cholesterolIBA
01/2022
1Calcitonin Gene-Related PeptideIBA
01/2022
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022
1TroponinIBA
10/2021
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2021
1IncretinsIBA
10/2021
1Cystatin MIBA
06/2021
1Carbonic Anhydrase IIIIBA
06/2021
1Keratin-8 (Keratin 8)IBA
01/2021
1FurinIBA
01/2021

Therapy/Procedure

1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022
1Transplantation
01/2022
1Aftercare (After-Treatment)
10/2021